CANINE COGNITION ASSESSMENTS IN THE TEST OF RAPAMYCIN IN AGING DOGS (TRIAD)
Sydney Holland, Anna Ferguson, Kate Creevy, Rozalyn Anderson, May Reed · 2024
Read CANINE COGNITION ASSESSMENTS IN THE TEST OF RAPAMYCIN IN AGING DOGS (TRIAD) by Sydney Holland, Anna Ferguson, Kate Creevy, Rozalyn Anderson, May Reed (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11692996.txt.
Description
Sydney Holland and four co-authors describe the baseline thinking tests inside a clinical trial of rapamycin in aging dogs. Their paper came out in 2024. The trial, run by the Dog Aging Project, asks whether the drug extends healthy life in middle-aged companion dogs, with cognition as a secondary outcome.
Thirty-five dogs passed screening and took two validated tests: one measuring how long a dog can hold its gaze, and a dementia scale scored by veterinary neurologists. The dogs were about nine years old on average and mostly scored near the healthy end of the dementia scale. No link appeared between test scores and age, weight, sex, or breed. The authors say this clean baseline lets the trial detect any real effect of the drug on age-related decline.
Catalog record
| CREATOR | Sydney Holland, Anna Ferguson, Kate Creevy, Rozalyn Anderson, May Reed |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |